CliffBio
biologic

Cerezyme

imiglucerase

Loss of exclusivitySeptember 2011projected — 12-year biologic exclusivity estimate
CompanyGenzyme Corporation

Drug detail

Brand nameCerezyme
Active ingredientimiglucerase
Strength400UNITS/VIAL
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
FDA approvalSeptember 1999
Marketing statusRx

More from Genzyme Corporation

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Cerezyme patent cliff — loss of exclusivity September 2011 | CliffBio